Antithrombin III for critically ill patients

Medicin og biovidenskab

• Antithrombin III 100%
• Critical Illness 73%
• Statistics 61%
• Odds Ratio 34%
• Disseminated Intravascular Coagulation 25%
• Sepsis 21%
• Heparin 14%
• Hemorrhage 13%
• Mortality 13%
• Multiple Organ Failure 12%
• Length of Stay 12%
• Randomized Controlled Trials 10%
• General Hospitals 10%
• Confidence Intervals 9%
• Intensive Care Units 8%
• Publications 8%
• cellulose acetate-butyrate 8%
• APACHE 6%
• Artificial Respiration 5%
• Respiratory Insufficiency 4%
• Anticoagulants 4%
• Obstetrics 4%
• Patient Selection 4%
• MEDLINE 4%
• Language 4%
• Erythrocytes 4%
• Data Analysis 3%
• Anti-Inflammatory Agents 3%
• Research Personnel 3%
• Health Care Outcome Assessment 3%
• Pediatrics 3%
• Databases 3%
• Inflammation 3%
• Blood Vessels 3%
• Incidence 2%
• Wounds and Injuries 2%
• Population 2%